Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

Summary

This is a non-randomized, phase II, open label study of postoperative current chemoradiotherapy for high-risk malignant salivary gland tumors of head and neck.The primary purpose of this study is to evaluate the efficacy and safety of concurrent chemoradiotherapy in these patients.

Timeline

Start

2016-06-01

Primary completion

2022-12-31

Completion

2023-12-31

Publications

• Dou S, Wang X, Zhang L, Jiang W, Ye L, Wang Y, Li R, Zhu G. Long-Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High-Risk Salivary Gland Carcinomas. Cancer Med. 2026 Mar;15(3):e71722. doi: 10.1002/cam4.71722.

Drugs

Indications